SM08502
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SM08502, covering 2024-08-09 to 2024-08-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors [Phase 1]